Refined By:
Type:  Other

Results 1-20 of 21 (Search time: 0.004 seconds).

Issue DateTitleAuthor(s)
11-Feb-2015Bile acid signaling through farnesoid X and TGR5 receptors in hepatobiliary and intestinal diseasesStanimirov, Bojan ; Stankov, Karmen ; Mikov, Momir 
225-Sep-2018Bile acid synthesis: From nature to the chemical modification and synthesis and their applications as drugs and nutrientsŠarenac, Dejan ; Mikov, Momir 
31-Jan-2017Bile acids as novel pharmacological agents: The interplay between gene polymorphisms, epigenetic factors and drug responseNebojša Pavlović ; Bojan Stanimirov ; Momir Mikov 
41-Jul-2006Bile acids: Chemistry, biosynthesis, analysis, chemical & metabolic transformations and pharmacologyMikov, Momir ; Fawcett J.
51-Jan-2006Biosynthesis of bile acids in mammalian liverKevresan S. ; Kuhajda K.; Kandrac J.; Fawcett J.; Mikov, Momir 
61-Jan-2014C-KIT signaling in cancer treatmentStankov, Karmen ; Popović, Živko; Mikov, Momir 
71-Jan-2019Cervical cancer, different treatments and importance of bile acids as therapeutic agents in this diseaseTanja Šarenac; Momir Mikov 
81-Jan-2006Chemical and metabolic transformations of selected bile acidsKuhajda K.; Kevresan S. ; Kandrac J.; Fawcett J.; Mikov, Momir 
91-Jan-2019DPP-4 Inhibitors: Renoprotective Potential and Pharmacokinetics in Type 2 Diabetes Mellitus Patients with Renal ImpairmentMikov, Momir ; Pavlović, Nebojša ; Stanimirov, Bojan ; Đanić, Maja ; Goločorbin-Kon, Svetlana ; Stankov, Karmen ; Al-Salami H.
101-Jul-2018An equation for tacrolimus daily dose calculation in renal transplant patients – Simple and cost saving?Rančić N.; Lozanov-Crvenković, Zagorka ; Mikov, Momir ; Vavić N.; Dragojević Simić V.
111-Apr-2012Ethical and legal aspects of oncogenomicsStankov, Karmen ; Drašković, Dragan ; Mikov, Momir 
121-Jan-2012The impact of farnesoid X receptor activation on intestinal permeability in inflammatory bowel diseaseStojancevic M.; Stankov, Karmen ; Mikov, Momir 
131-Jan-2014The influence of intestinal tract and probiotics on the fate of orally administered drugsStojančević M.; Bojić G.; Al Salami H.; Mikov, Momir 
141-Oct-2012An insight on differences in availability and reimbursement of orphan medicines among Serbia, Bulgaria and SwedenPavlović, Nebojša ; Stanimirov, Bojan ; Stojančević M.; Paut-Kusturica M.; Stoimenova A.; Goločorbin-Kon, Svetlana ; Mikov, Momir 
151-Jan-2006Isolation and determination of bile acidsKandrac J.; Kevresan S. ; Gu J.; Mikov, Momir ; Fawcett J.; Kuhajda K.
161-Feb-2013Pharmacogenetic biomarkers as tools for pharmacoepidemiology of severe adverse drug reactionsStankov, Karmen ; Sabo, Ana ; Mikov, Momir 
171-Jan-2018Pharmacological applications of bile acids and their derivatives in the treatment of metabolic syndromeMaja Đanić ; Bojan Stanimirov ; Nebojša Pavlović ; Svetlana Goločorbin-Kon ; Hani Al-Salami; Karmen Stankov ; Momir Mikov 
181-Jan-2006Pharmacology of bile acids and their derivatives: Absorption promoters and therapeutic agentsMikov, Momir ; Fawcett J.; Kuhajda K.; Kevresan S. 
191-Dec-2012Pleiotropic functions of bile acids mediated by the farnesoid X receptorStanimirov, Bojan ; Stankov, Karmen ; Mikov, Momir 
201-Jun-2018Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and ProbioticsMomir Mikov ; Maja Đanić ; Nebojša Pavlović ; Bojan Stanimirov ; Svetlana Goločorbin-Kon ; Karmen Stankov ; Hani Al-Salami